179 related articles for article (PubMed ID: 33592381)
1. Age and sex adjusted prevalence and annual incidence of multiple sclerosis in East-Azerbaijan, Iran.
Talebi M; Sadigh-Eteghad S; Sahraian MA; Fahidi A
Mult Scler Relat Disord; 2021 May; 50():102839. PubMed ID: 33592381
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Epidemiological Aspects of Late Onset Multiple Sclerosis in East-Azerbaijan, Iran; A Population-Based Study.
Nasiri E; Naseri A; Abbasgholizadeh P; Fahidi A; Talebi M
Arch Iran Med; 2022 Nov; 25(11):725-729. PubMed ID: 37543896
[TBL] [Abstract][Full Text] [Related]
3. Estimating the incidence rate of hepatitis B and C in East Azerbaijan, Islamic Republic of Iran.
Somi MH; Khayatzadeh S; Nalbandy M; Naghashi S; Nikniaz Z
East Mediterr Health J; 2020 Jul; 26(7):803-809. PubMed ID: 32794166
[TBL] [Abstract][Full Text] [Related]
4. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
Etemadifar M; Maghzi AH
Mult Scler; 2011 Aug; 17(8):1022-7. PubMed ID: 21459809
[TBL] [Abstract][Full Text] [Related]
5. Multiple Sclerosis in Tehran: Rising Prevalence alongside Stabilizing Incidence - True Increase or Enhanced Diagnosis?
Mohebi F; Eskandarieh S; Mansournia MA; Mohajer B; Sahraian MA
Arch Iran Med; 2019 Aug; 22(8):429-434. PubMed ID: 31679345
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Multiple Sclerosis in Torbat-e Heydarieh (Northeast of Iran) during 1982-2016.
Moghaddam VK; Sarmadi M; Tatari M; Najafi F; Esmaeili A; Hadei M
Mult Scler Relat Disord; 2018 Aug; 24():184-189. PubMed ID: 30077941
[TBL] [Abstract][Full Text] [Related]
7. A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.
Elhami SR; Mohammad K; Sahraian MA; Eftekhar H
Neuroepidemiology; 2011; 36(3):141-7. PubMed ID: 21508646
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal cancer incidence in East Azerbaijan, Iran: update on 5 year incidence and trends.
Somi MH; Golzari M; Farhang S; Naghashi S; Abdollahi L
Asian Pac J Cancer Prev; 2014; 15(9):3945-9. PubMed ID: 24935578
[TBL] [Abstract][Full Text] [Related]
9. Temporal Incidence and Prevalence Trends of Multiple Sclerosis in Markazi Province, Iran.
Faraji F; Ahmadi F; Mohaghegh P; Talaie A
Mult Scler Relat Disord; 2022 Apr; 60():103691. PubMed ID: 35217485
[TBL] [Abstract][Full Text] [Related]
10. Incidence and prevalence of multiple sclerosis in southeastern Iran.
Moghtaderi A; Rakhshanizadeh F; Shahraki-Ibrahimi S
Clin Neurol Neurosurg; 2013 Mar; 115(3):304-8. PubMed ID: 22717599
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and incidence of multiple sclerosis in Ardabil, Northwest of Iran.
Molazadeh N; Mohebi F; Altafi D; Sahraian MA
Mult Scler Relat Disord; 2021 Jan; 47():102605. PubMed ID: 33217696
[TBL] [Abstract][Full Text] [Related]
12. Temporal trends of incidence and prevalence of multiple sclerosis in Razavi Khorasan Province, Northeast Iran.
Sarmadi M; Saravani H; Azizi O; Najafi F; Hadei M; Momeni J; Bazrafshan E
Neurol Sci; 2022 Jan; 43(1):583-591. PubMed ID: 33939041
[TBL] [Abstract][Full Text] [Related]
13. Cancer incidence in the East Azerbaijan province of Iran in 2015-2016: results of a population-based cancer registry.
Somi MH; Dolatkhah R; Sepahi S; Belalzadeh M; Sharbafi J; Abdollahi L; Nahvijou A; Nemati S; Malekzadeh R; Zendehdel K
BMC Public Health; 2018 Nov; 18(1):1266. PubMed ID: 30453968
[TBL] [Abstract][Full Text] [Related]
14. Ongoing increase in incidence and prevalence of multiple sclerosis in south-eastern Iran: A three decade study.
Moghtaderi A; Shahidi-Pourakbari M; Izadi S; Khosravi A; Hashemzehi Z
Mult Scler Relat Disord; 2023 Mar; 71():104557. PubMed ID: 36857854
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Epidemiological Findings of Pediatric Onset Multiple Sclerosis in East-Azerbaijan, Iran; A Population-based Study.
Nasiri E; Naseri A; Talebi M
Iran J Child Neurol; 2023; 17(3):109-119. PubMed ID: 37637785
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of multiple sclerosis in Isfahan, Iran.
Etemadifar M; Janghorbani M; Shaygannejad V; Ashtari F
Neuroepidemiology; 2006; 27(1):39-44. PubMed ID: 16804333
[TBL] [Abstract][Full Text] [Related]
17. Incidence of multiple sclerosis in Iran: a nationwide, population-based study.
Hosseinzadeh A; Baneshi MR; Sedighi B; Kermanchi J; Haghdoost AA
Public Health; 2019 Oct; 175():138-144. PubMed ID: 31476710
[TBL] [Abstract][Full Text] [Related]
18. Age and sex-adjusted incidence and yearly prevalence of multiple sclerosis (MS) in Mazandaran province, Iran: An 11-years study.
Cheraghmakani H; Baghbanian SM; HabibiSaravi R; Azar A; Ghasemihamedani F
PLoS One; 2020; 15(7):e0235562. PubMed ID: 32614900
[TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis in Isfahan, Iran.
Saadatnia M; Etemadifar M; Maghzi AH
Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
[TBL] [Abstract][Full Text] [Related]
20. Is the sharp increasing trend of multiple sclerosis incidence real in Iran?
Hosseinzadeh A; Sedighi B; Kermanchi J; Heidari M; Haghdoost AA
BMC Neurol; 2021 Jan; 21(1):7. PubMed ID: 33407243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
